Table 2.
Univariate Associations of Clinical Factors by Clinical Status at Baseline and Month 4
|
Clinical Factor |
Baseline |
Month 4 |
||||||
|---|---|---|---|---|---|---|---|---|
| Never Achieved P/C Remission | Achieved P/C Remission and Relapsed | Achieved and Maintained P/C Remission | P-Value | Never Achieved P/C Remission | Achieved P/C Remission and Relapsed | Achieved and Maintained P/C Remission | P-Value | |
| BPDAI TAS | 21 (7–47.6) | 16.1 (8–35) | 16.9 (5–40) | 0.816 | 5.9 (5–81) | 3.9 (3–5) | 2.9 (1–4.8) | 0.080 |
| BPDAI PCS | 18 (11–26) | 21 (9–28) | 19 (8–24) | 0.620 | 0 (0–30) | 9.5 (6–15) | 3 (0–15) | 0.592 |
| Anti-BP180 IgG (U/ml) | 50 (0–88) | 62 (12–147) | 19 (0–107) | 0.573 | 18.5 (10–27) | 12.5 (10–15) | 45 (26–54) | 0.288 |
| Anti-BP230 IgG (U/ml) | 0 (0–0) | 0 (0–29) | 0 (0–50) | 0.071 | 0 (0–0) | 36.5 (19–54) | 21 (10–40) | 0.351 |
Abbreviations: BPDAI, Bullous Pemphigoid Disease Area Index; PCS, pruritus component score; P/C, partial/complete; Q, quartile; TAS, total activity score.
At baseline: never achieved P/C remission, n = 22; achieved P/C remission and relapsed, n = 26; and achieved and maintained P/C remission, n = 32. Data are presented as median (Q1, Q3); nonparametric values calculated using the Kruskal‒Wallis test.